Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

1.

Competing cardiovascular and noncardiovascular risks and longevity in the systolic hypertension in the elderly program.

Kostis WJ, Cabrera J, Messerli FH, Cheng JQ, Sedjro JE, Cosgrove NM, Swerdel JN, Deng Y, Davis BR, Kostis JB.

Am J Cardiol. 2014 Feb 15;113(4):676-81. doi: 10.1016/j.amjcard.2013.11.013. Epub 2013 Nov 23.

PMID:
24388619
2.

Visit-to-visit blood pressure variability and cardiovascular death in the Systolic Hypertension in the Elderly Program.

Kostis JB, Sedjro JE, Cabrera J, Cosgrove NM, Pantazopoulos JS, Kostis WJ, Pressel SL, Davis BR.

J Clin Hypertens (Greenwich). 2014 Jan;16(1):34-40. doi: 10.1111/jch.12230. Epub 2013 Dec 11.

PMID:
24325609
3.

Association between chlorthalidone treatment of systolic hypertension and long-term survival.

Kostis JB, Cabrera J, Cheng JQ, Cosgrove NM, Deng Y, Pressel SL, Davis BR.

JAMA. 2011 Dec 21;306(23):2588-93. doi: 10.1001/jama.2011.1821.

PMID:
22187278
4.

Atrial fibrillation and isolated systolic hypertension: the systolic hypertension in the elderly program and systolic hypertension in the elderly program-extension study.

Vagaonescu TD, Wilson AC, Kostis JB.

Hypertension. 2008 Jun;51(6):1552-6. doi: 10.1161/HYPERTENSIONAHA.108.110775. Epub 2008 Apr 7.

5.

Long-term fatal outcomes in subjects with stroke or transient ischemic attack: fourteen-year follow-up of the systolic hypertension in the elderly program.

Patel AB, Kostis JB, Wilson AC, Shea ML, Pressel SL, Davis BR.

Stroke. 2008 Apr;39(4):1084-9. doi: 10.1161/STROKEAHA.107.500777. Epub 2008 Feb 28.

6.

Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.

Wright JT Jr, Dunn JK, Cutler JA, Davis BR, Cushman WC, Ford CE, Haywood LJ, Leenen FH, Margolis KL, Papademetriou V, Probstfield JL, Whelton PK, Habib GB; ALLHAT Collaborative Research Group.

JAMA. 2005 Apr 6;293(13):1595-608.

PMID:
15811979
7.

Management of hypertension in the very elderly patient.

Elliott WJ.

Hypertension. 2004 Dec;44(6):800-4. Epub 2004 Oct 25.

8.

Trandolapril: a newer angiotensin-converting enzyme inhibitor.

Guay DR.

Clin Ther. 2003 Mar;25(3):713-75. Review.

PMID:
12852701
9.

Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP).

Kostis JB, Berge KG, Davis BR, Hawkins CM, Probstfield J.

Am J Hypertens. 1995 Dec;8(12 Pt 1):1147-53.

PMID:
8998247
11.

Systolic hypertension in the elderly: controlled or uncontrolled.

Probstfield JL, Furberg CD.

Cardiovasc Clin. 1990;20(3):65-84. Review.

PMID:
2186867
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk